Skip to main content
. 2023 Sep 2;58(6):536–541. doi: 10.4085/1062-6050-0207.22

Table 3.

Participant Demographics, Patient-Reported Function, and Quadriceps Strength


Demographic

Group (No. [%])

P Value

Both Strong and Symmetric (26 [15.0])

Strong Only (4 [2.3])

Symmetric Only (30 [17.3])

Neither Strong Nor Symmetric (113 [65.4])
Sex, No., males/females 18/8 3/1 11./19 41/72 .09
Age, mean ± SD, y 18.5 ± 3.3 20.2 ± 1.9 18.0 ± 3.5 19.0 ± 3.6 .44
Body mass index, mean ± SD, kg/m2 23.2 ± 3.3 21.9 ± 2.7 25.0 ± 5.0 25.0 ± 4.7 .22
Time since surgery, mean ± SD, mo 6.2 ± 0.55 5.8 ± 0.75 6.1 ± 0.55 6.0 ± 0.54 .46
Graft source, No. .008
 Bone-patellar tendon-bone 2 0 1 35
 Hamstrings autograft 22 2 28 67
 Quadriceps tendon autograft 0 1 0 8
 Allograft 2 1 1 2
 Unknown 0 0 0 1
Meniscal surgery at time of ACLR, % 46.2 25.0 50.0 55.8 .53
Tegner Activity Score, median [interquartile range]
 Preinjury 10 [1] 10 [0.25] 9 [2] 9 [2] .003a
 Current 7.5 [3] 6.5 [1.75] 6 [2] 6 [2] .002a
Quadriceps strength, mean ± SD, Nm/kg
 ACLR limb 3.61 ± 0.44 3.74 ± 0.66 2.41 ± 0.41 2.13 ± 0.49 <.001a
 Uninvolved limb 3.59 ± 0.49 4.33 ± 0.73 2.45 ± 0.43 3.06 ± 0.59 <.001a
Quadriceps strength limb symmetry index, mean ± SD, % 101.0 ± 7.2 86.4 ± 0.88 98.7 ± 6.6 70.8 ± 14.2 <.001a

Abbreviation: ACLR, anterior cruciate ligament reconstruction.

a

Indicates a significant difference.